Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union profile picture

Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union

Is this your author profile? Create an account to customize it!

Stand Alone

Regulatory Processes for Rare Disease Drugs in the United States and European Union Flexibilities and Collaborative Opportunities
Regulatory Processes for Rare Disease Drugs in the United States and European Union Flexibilities and Collaborative Opportunities
Regulatory Processes for Rare Disease Drugs in the United States and European Union: Flexibilities and Collaborative Opportunities
Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union | MenrvaBooks